Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (5818)	12/29/1998 3:02:00 PM
From: scaram(o)uche	Respond to of 6136

57. Congrats, Johnson et al. Congrats, shareholders!

To: Izzy who wrote (5818)	12/29/1998 3:03:00 PM
From: billkirn	Read Replies (1) \| Respond to of 6136

Congrads. DR Oliver. Very exciting and meaningful time. Bill

To: Izzy who wrote (5818)	12/29/1998 3:10:00 PM
From: JOHN W.	Read Replies (2) \| Respond to of 6136

My PW broker told me it is short covering that is causing this increase, not Viracept or the last night exposure to the National Media Coverage of their Cure For the Common Cold. The comparison to the internet stocks is interesting. The cure for the common cold will be on the shelves of every supermarket in the world well before UBID even gets in the black or AMZN comes close to AGPHs revenues. Food for thought. AGPH IR told me that every type of Rhinovirus that AG 7088 has been tested on has worked, clinical trials are going extremely well and that this is a very safe drug! I hope that AGPH does not sell out to big pharma, but I think if they get an offer close to 100 from DD, they will. Good Luck to all. I have had this cold for 3 days now, I wish AGPH could give me some of this cure for the common cold. Curious, how many of the posters have gotten sick this winter?